https://stock.noler.com/us/stock/portola-pharmaceuticals-inc https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/accrued-advertising-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/asset-impairment-charges https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/available-for-sale-gross-unrealized-gain-loss https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/available-for-sale-gross-unrealized-gains https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/available-for-sale-gross-unrealized-loss https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/available-for-sale-securities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/buybacks-payments-for-repurchase-of-other-equity https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/capitalized-contract-cost-gross https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/comprehensive-income-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/contract-liability https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/contract-with-customer-asset-net https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/contract-with-customer-asset-net-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/contract-with-customer-liability-cumulative-catch-up-adjustment-to-revenue-change-in-estimate-of-transaction-price https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/contract-with-customer-performance-obligation-satisfied-in-previous-period https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/cost-of-goods-and-services-sold-amortization https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/cost-of-goods-sold-amortization https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/cost-of-revenue https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/cumulative-effect-on-retained-earnings-net-of-tax https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/current-federal-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/decrease-in-restricted-cash https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-federal-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-offering-costs https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/derivative-liabilities-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/derivative-notional-amount https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/dilutive-shares https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/due-from-related-parties-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/embedded-derivative-gain-loss-on-embedded-derivative-net https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/embedded-derivative-loss-on-embedded-derivative https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-into-level https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-out-of-level https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/foreign-currency-transaction-gain-loss-realized https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/gain-loss-on-foreign-currency-non-hedging-derivatives https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/gain-loss-on-sale-of-derivatives https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-contract-with-customer-asset https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/increase-in-restricted-cash https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/intangible-assets-net-including-goodwill https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/interest-receivable-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/inventory-firm-purchase-commitment-loss https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/inventory-lifo-reserve-effect-on-income-net https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/inventory-noncurrent https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/inventory-raw-materials https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/inventory-work-in-process https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/inventory-write-down https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/investment-foreign-currency-contract-foreign-currency-amount https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/investment-income-amortization-of-premium https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/lease-cost https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/level-3-asset-transfers-into-level https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/level-3-asset-transfers-out-of-level https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/level-3-liability-issues https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/level-3-liability-settlements https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/license-and-services-revenue https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/long-term-investments https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/long-term-notes-payable https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/loss-on-contract-termination-for-default https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/minority-interest https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/minority-interest-change https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/minority-interest-decrease-from-distributions-to-noncontrolling-interest-holders https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/non-hedging-derivatives-gain-loss-net https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/notional-amount-of-foreign-currency-derivative-sale-contracts https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-cost https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/other-commitment-due-in-next-twelve-months https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/other-commitment-due-in-second-year https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/other-commitments-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/other-current-liabilities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/other-deferred-costs-net https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/other-long-term-debt-noncurrent https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/other-noncash-income-expense https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/other-operating-activities-cash-flow-statement https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/other-receivables-net-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/paid-in-capital-other https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/paid-in-kind-interest https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/patents-pending https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/payments-for-restructuring https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/payments-for-underwriting-expense https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/payments-of-dividends-minority-interest https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/preferred-stock-dividends-and-other-adjustments https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/prepaid-expense-and-other-assets-noncurrent https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/prepaid-expense-other-noncurrent https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/prepaid-insurance https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/purchase-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/purchase-obligation-due-in-second-year https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/purchase-obligation-due-in-third-year https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/repayments-of-debt https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/restructuring-and-related-cost-expected-cost-remaining https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/restructuring-and-related-cost-number-of-positions-eliminated https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/restructuring-charges https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/restructuring-reserve-current https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/revenue-remaining-performance-obligation https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-15-12b https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-certnas https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-sc-14d9 https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-sc-to-c https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-sc-to-t https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sec-filings-sc14d9c https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/secondary-offerings-form-drs https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/secondary-offerings-form-posasr https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/secondary-offerings-form-s-1mef https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/short-term-investments https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/short-term-lease-cost https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-award-compensation-cost https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/stockholders-equity-note-stock-split-conversion-ratio https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/tax-rate-reconciliation-repatriation-of-foreign-earnings https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/temporary-equity-redemption-value https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/total-contract-liability https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/undistributed-earnings-allocated-to-participating-securities https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/undistributed-earnings-diluted https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/utb-change https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/variable-interest-entity-initial-consolidation-gain-or-loss https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/portola-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted